Adiposopathy: why do adiposity and obesity cause metabolic disease?
- 1 August 2006
- journal article
- Published by Taylor & Francis in Future Lipidology
- Vol. 1 (4) , 389-420
- https://doi.org/10.2217/17460875.1.4.389
Abstract
No abstract availableThis publication has 102 references indexed in Scilit:
- Association of Interleukin-6, C-reactive Protein, Interleukin-10 and Adiponectin Plasma Concentrations with Measures of Obesity, Insulin Sensitivity and Glucose MetabolismExperimental and Clinical Endocrinology & Diabetes, 2005
- Adipose tissues as an ancestral immune organ: Site‐specific change in obesityPublished by Wiley ,2005
- Acid Ceramidase Overexpression Prevents the Inhibitory Effects of Saturated Fatty Acids on Insulin SignalingJournal of Biological Chemistry, 2005
- Proteomic Analysis of Proteins Associated with Lipid Droplets of Basal and Lipolytically Stimulated 3T3-L1 AdipocytesJournal of Biological Chemistry, 2004
- Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoproteinBiochemical Society Transactions, 2003
- Acylation stimulating protein stimulates insulin secretionInternational Journal of Obesity, 2003
- Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South AsiansInternational Journal of Obesity, 2001
- Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesityMedical Hypotheses, 2001
- Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populationsEuropean Journal of Clinical Investigation, 1999
- TNF‐α inhibits glucose‐induced insulin secretion in a pancreatic β‐cell line (INS‐1)FEBS Letters, 1995